Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study

BACKGROUND: Access to clinical trials and especially early-phase trials (ECT) is an important issue in geriatric oncology. As cancer can be considered an age-related disease because the incidence of most cancers increases with age, new drugs should also be evaluated in older patients to assess their...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldini, C., Charton, E., Schultz, E., Auroy, L., Italiano, A., Robert, M., Coquan, E., Isambert, N., Moreau, P., Le Gouill, S., Le Tourneau, C., Ghrieb, Z., Kiladjian, J.J., Delord, J.P., Roca, C. Gomez, Vey, N., Barlesi, F., Lesimple, T., Penel, N., Soria, J.C., Massard, C., Besle, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271476/
https://www.ncbi.nlm.nih.gov/pubmed/35533427
http://dx.doi.org/10.1016/j.esmoop.2022.100468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271476/
https://www.ncbi.nlm.nih.gov/pubmed/35533427
http://dx.doi.org/10.1016/j.esmoop.2022.100468

Ejemplares similares